SEC Form 4/A · accession 0001179110-15-010496
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Nesli Basgoz
Director
Period of report
Jun 5, 2015
Accepted (ET)
Jun 30, 2015 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001 | Jun 4, 2015 | F | 334 | $303.38 | D | 3,460 | D | |
| Ordinary Shares, par value $0.0001F1 | Jun 5, 2015 | A | 826 | $302.30 | A | 4,286 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person's Form 4 initially filed with the Securities and Exchange Commission (the "Commission") on June 8, 2015 (the "Initial Form 4") is being re-reported solely to gain access to the electronic filing system to file this Amendment. The Initial Form 4 reported a transaction on June 5, 2015 as an acquisition of restricted stock, however the transaction was an acquisition of restricted stock units, which vest as set out in the Initial Form 4.